|
|
|
 |
 Congress at a Glance |
|
Scientific Programme
|
|
Satellite Programme
|
|
Maps of the Venue
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
| 09:00-11:05
|
|
S.09:
 Treatment track
Developments in the treatment of Alzheimer's disease |
|
| Chairs: |
Ezio Giacobini, Switzerland |
| |
Walter Pirker, Austria |
|
|
|
|
| 09:50 |
|
|
S.09.03
Amyloid hypothesis in dementia: where do we stand?
|
|
|
Christoph Hock, Switzerland
|
|
|
|
| 09:00-11:05
|
|
S.10:
 Clinical research track
Unraveling the causes of autism |
|
| Chairs: |
Jan K. Buitelaar, The Netherlands |
| |
Rainald Mössner, Germany |
|
|
|
|
| 09:00 |
|
|
S.10.01
Brain mechanisms underlying autistic behaviour
|
|
|
Christopher Gillberg, Sweden
|
|
|
|
| 09:25 |
|
|
S.10.02
The link between middle ear disease and autistic spectrum disorder
|
|
|
Jean Golding, United Kingdom
|
|
|
|
| 10:15 |
|
|
S.10.04
Autism genes and autism endophenotypes: head circumference, body growth and biochemical markers
|
|
|
Antonio M. Persico, Italy
|
|
|
|
| 10:40 |
|
|
S.10.05
Chromosomal microdeletions and duplications (CNVs) and the discovery of new autism genes
|
|
|
Rainald Mössner, Germany
|
|
|
|
| 09:00-11:05
|
|
S.11:
 Interface track
TEM symposium - Preclinical and translational research in improving clinical outcomes in anxiety disorders |
|
| Chairs: |
Nicoletta Brunello, Italy |
| |
Johan A. den Boer, The Netherlands |
|
| Johan A. den Boer, The Netherlands will be replaced by Astrid Linthorst, United Kingdom |
|
|
| 09:00-11:05
|
|
S.12:
 Preclinical track
Breaking News 1 |
|
| Chairs: |
Filippo Drago, Italy |
| |
Gabriele Fischer, Austria |
|
|
|
|
| 09:00 |
|
|
S.12.01
Behavioural genetics of avoidance; a mouse phenotype linked to a human mood disorder
|
|
|
Annetrude de Mooij-van Malsen, The Netherlands
|
|
|
|
| 09:25 |
|
|
S.12.02
Long-term antipsychotic exposure does not target in vivo the D3 receptors in schizophrenia: a [11C]-(+)-PHNO PET study
|
|
|
Ariel Graff-Guerrero, Canada
|
|
|
|
| 09:50 |
|
|
S.12.03
Catechol-o-methyltransferase (COMT) gene modulates neural response to cannabis in healthy volunteers
|
|
|
Sagnik Bhattacharyya, United Kingdom
|
|
|
|
| 10:15 |
|
|
S.12.04
Lipid raft localization of Gsalpha is a putative biomarker for depression and antidepressant efficacy
|
|
|
Mark Rasenick, USA
|
|
|
|
| 10:40 |
|
|
S.12.05
The neurokinin 1 receptor as a possible treatment target for alcoholism - effect on reward and escalation
|
|
|
Annika Thorsell, USA
|
|
|
|
|
|
|
Treatment
track
Clinical
research track
Interface
track
Preclinical
track
Educational updates
track